The Associated Press |
As If a Stoke Isn't Bad Enough
Posted by Zelnorm (Zelnorm) on Wed, 05 Sep 2007 00:16:19 +0000
Health and Age.com - IBS Patients - Zelnorm® is Back August 23, 2007 Irritable bowel syndrome (IBS) patients with constipation-type IBS suffered a setback in March of this year when the FDA asked Novartis to withdraw the tegaserod (Zelnorm®) because of an increased ...
Medscape Alerts Index
Medscape News - Recalls & Warnings FDA Announces Restricted Access Program for Zelnorm Partially lifting the marketing suspension in effect since March 2007, the FDA now allows the use of tegaserod maleate for irritable bowel syndrome with constipation and chronic ...
Press Release Tips and Template
PRWeb - Zelnorm Action Group and IBS Self Help Group Speak on Behalf of the Chronic Constipation and Irritable Bowel Syndrome Sufferer Zelnorm is a much needed drug for the relief of chronic constipation and constipation predominant IBS sufferers - 2004-06-18 ...
FDA more wary of new drugs
Centre Daily - The FDA also has recently stiffened warnings on several drugs, most prominently diabetes drugs Avandia and Actos, and five months ago made Novartis withdraw its constipation drug, Zelnorm. "There have been no systematic changes in how we are ...
Public Health & Prevention News CME Index
Medscape News - ... FDA Approvals: Zelnorm The FDA has approved restricted use of tegaserod maleate under an investigational new drug protocol program....
Original post: As If a Stoke Isn't Bad Enough by Copyright © 2007 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Live Search results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions. at Live Search News: zelnorm
Clean out the medicine cabinet: - Union Sentinel
Posted by Zelnorm (Zelnorm) on Sun, 02 Sep 2007 23:15:48 +0000
Clean out the medicine cabinet:Union Sentinel, GA -Aug 31, 2007This year the Federal Drug Administration (FDA) asked major drug manufacturer Novartis to voluntarily pull their popular prescription medication Zelnorm... |
FDA to Allow Limited Use of Zelnorm - FDA news (subscription)
FDA to Allow Limited Use of ZelnormFDA news (subscription), VA -Aug 3, 2007The FDA has decided certain patients will be able to take Novartis’ Zelnorm, despite the fact that Novartis withdrew the drug from the market at the ... |
Constipation's Many Causes and Cures - Forbes
Public Health & Prevention News CME Index
Posted by Zelnorm (Zelnorm) on Sun, 02 Sep 2007 00:16:04 +0000
Medscape News - ... FDA Approvals: Zelnorm The FDA has approved restricted use of tegaserod maleate under an investigational new protocol program.
Global markets on the rebound as well
Newburyport Daily News - The FDA also has recently stiffened warnings on several drugs, most prominently diabetes drugs Avandia and Actos, and five months ago made Novartis withdraw its constipation drug, Zelnorm. Dell accounting woes may cost $150M DALLAS (AP) - Dell Inc ...
Should You Stop Using Zelnorm? Save Email Print
WVLT - Knoxville (WVLT) - A popular drug used to treat irritable bowel syndrome has been pulled from the US market, amid new evidence it raises the risk of heart attack and stroke. Zelnorm is used by thousands of women to treat one of the most common ...
FDA Permits Restricted Use of Zelnorm for Qualifying Patients
WebWire - The U.S. Food and Drug Administration announced that it is permitting the restricted use of Zelnorm (tegaserod maleate) under a treatment investigational new drug (IND) protocol to treat irritable bowel syndrome with constipation (IBS-C) and chronic ...
The Nissen Doctrine
Forbes - Zelnorm, from Novartis (nyse: NVS - news - people ), was pulled because of a similar analysis. But you wouldn't know that from the controversy sparked by Nissen's analysis. He was grilled before Congress, partly because in trying to ... ...
Original post: Public Health & Prevention News CME Index by Copyright © 2007 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Live Search results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions. at Live Search News: zelnorm
Press Release Tips and Template
Posted by Zelnorm (Zelnorm) on Sun, 26 Aug 2007 00:15:41 +0000
PRWeb - Zelnorm Action Group and IBS Self Help Group Speak on Behalf of the Chronic Constipation and Irritable Bowel Syndrome Sufferer Zelnorm is a much needed for the relief of chronic constipation and constipation predominant IBS sufferers - 2004-06-18 ...
FDA more wary of new drugs
Centre Daily - The FDA also has recently stiffened warnings on several drugs, most prominently diabetes drugs Avandia and Actos, and five months ago made Novartis withdraw its constipation drug, Zelnorm. "There have been no systematic changes in how we are ...
Public Health & Prevention News CME Index
Medscape News - ... FDA Approvals: Zelnorm The FDA has approved restricted use of tegaserod maleate under an investigational new drug protocol program.
Global markets on the rebound as well
Newburyport Daily News - The FDA also has recently stiffened warnings on several drugs, most prominently diabetes drugs Avandia and Actos, and five months ago made Novartis withdraw its constipation drug, Zelnorm. Dell accounting woes may cost $150M DALLAS (AP) - Dell Inc ...
Should You Stop Using Zelnorm? Save Email Print
WVLT - Knoxville (WVLT) - A popular drug used to treat irritable bowel syndrome has been pulled from the US market, amid new evidence it raises the risk of heart attack and stroke. Zelnorm is used by thousands of women to treat one of the most common ... ...
Original post: Press Release Tips and Template by Copyright © 2007 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Live Search results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions. at Live Search News: zelnorm
Public Health & Prevention News CME Index
Posted by Zelnorm (Zelnorm) on Fri, 24 Aug 2007 00:22:58 +0000
Medscape News - ... FDA Approvals: Zelnorm The FDA has approved restricted use of tegaserod maleate under an investigational new drug protocol program.
Global markets on the rebound as well
Newburyport Daily News - The FDA also has recently stiffened warnings on several drugs, most prominently diabetes drugs Avandia and Actos, and five months ago made Novartis withdraw its constipation drug, Zelnorm. Dell accounting woes may cost $150M DALLAS (AP) - Dell Inc ...
Should You Stop Using Zelnorm? Save Email Print
WVLT - Knoxville (WVLT) - A popular drug used to treat irritable bowel syndrome has been pulled from the US market, amid new evidence it raises the risk of heart attack and stroke. Zelnorm is used by thousands of women to treat one of the most common ...
Medscape Alerts Index
Medscape News - Recalls & Warnings FDA Announces Restricted Access Program for Zelnorm Partially lifting the marketing suspension in effect since March 2007, the FDA now allows the use of tegaserod maleate for irritable bowel syndrome with constipation and chronic ...
Novartis Drug Returns On a Restricted Basis
Wall Street Journal - WASHINGTON -- The Food and Drug Administration said Friday it will allow restricted use of Zelnorm, a Novartis AG drug used to treat irritable bowel syndrome. The drug was pulled off the U.S. market in March after a study linked it to increased risk ... ...
Original post: Public Health & Prevention News CME Index by Copyright © 2007 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Live Search results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions. at Live Search News: zelnorm
Novartis agrees restrictive access program for Zelnorm with US FDA - Forbes
Posted by Zelnorm (Zelnorm) on Thu, 23 Aug 2007 00:18:44 +0000
FDA to Allow Limited Use of Zelnorm - FDA news (subscription)
FDA to Allow Limited Use of ZelnormFDA news (subscription), VA -Aug 3, 2007The FDA has decided certain patients will be able to take Novartis’ Zelnorm, despite the fact that Novartis withdrew the drug from the market at the ... |
FDA to allow Zelnorm under restricted access - Pharmaceutical Business Review
tegaserod (Zelnorm) Drug Information by MedicineNet.com
Posted by Zelnorm (Zelnorm) on Wed, 22 Aug 2007 23:16:37 +0000
Read about Zelnorm (tegaserod) a medication used to treat IBS (irritable bowel syndrome) ... restricted use of tegaserod (Zelnorm) for patients for whom other ...
IBS Drug Zelnorm Taken Off U.S. Market
The FDA announced that the irritable bowel syndrome drug Zelnorm is being voluntarily taken off the market because of possible cardiovascular risks.
FDA Announces Discontinued Marketing of GI Drug, Zelnorm, for Safety Reasons
FDA Announces Discontinued Marketing of GI Drug, Zelnorm, for Safety Reasons ... voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently ...
Zelnorm - Safer Alternatives to Zelnorm for Irritable Bowel Syndrome (IBS) Constipation
Zelnorm - Safer Alternatives to Zelnorm Medication for Constipation & Bloating from Irritable Bowel Syndrome (IBS) ... Zelnorm is a new medication meant for ...
Zelnorm - Novartis Pharmaceuticals Canada - Beinvenue - Welcome
Offers patient and prescribing information for its use treating the symptoms of Irritable Bowel Syndrome. From Novartis....
Original post: tegaserod (Zelnorm) Drug Information by MedicineNet.com by Copyright (c) 2007 Yahoo! Inc. All rights reserved. at Yahoo! Search: zelnorm
FDA rejections likely to raise cost to develop drugs - Houston Chronicle
Posted by Zelnorm (Zelnorm) on Wed, 22 Aug 2007 00:15:59 +0000
FDA to Allow Limited Use of Zelnorm - FDA news (subscription)
FDA to Allow Limited Use of ZelnormFDA news (subscription), VA -Aug 3, 2007The FDA has decided certain patients will be able to take Novartis’ Zelnorm, despite the fact that Novartis withdrew the drug from the market at the ... |
FDA to allow Zelnorm under restricted access - Pharmaceutical Business Review
Global markets on the rebound as well (Eagle-Tribune Online)
Posted by Zelnorm (Zelnorm) on Tue, 21 Aug 2007 23:22:47 +0000
LONDON (AP) - Markets across the globe, save for Asia, rebounded yesterday after the U.S. Federal Reserve cut its primary discount rate, a surprise move aimed at easing credit and calming financial markets.
Agency slow to OK drugs (San Jose Mercury News)
TRENTON, N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a host of experimental drugs or delayed their approval and required more data.
Business Highlights (AP via Yahoo! Finance)
The Federal Reserve approved a half-percentage point cut in its discount rate on loans to banks Friday, a dramatic move designed to stabilize financial markets roiled by a widening credit crisis.
FDA errs on side of caution in approvals (Minneapolis-St. Paul Star Tribune)
TRENTON, N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration (FDA) in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs some patients might desperately need off the market, the rejections have battered drug company stock prices and are ...
Experts say FDA more cautious about drug approvals (Lansing State Journal)
TRENTON, N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market in 2004, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data....
Original post: Global markets on the rebound as well (Eagle-Tribune Online) by Copyright (c) 2004 Yahoo! Inc. All rights reserved. at Yahoo! News Search Results for zelnorm
Pages: Start 1
|
|
|
|
